BioNTech, the German biopharmaceutical company behind one of the world's first COVID-19 vaccines, has announced a landmark investment of up to £1 billion in the UK over the next decade.
As your specialist in Acute Care, Draeger Medical UK Ltd is focused on providing protective therapy solutions in the operating room, intensive care unit and neonatal intensive care unit. The aim has always been to improve clinical outcomes and reduce risks in acute care; which has never been truer than in the time of a global pandemic.
Bernard Ross, CEO of Sky Medical Technology, looks at how wearable medical technology can address some of the most critical medical issues of the 21st Century.
When it comes to facing the COVID pandemic, healthcare professionals were at the frontline and new research suggests that 47% of critical care nurses are at risk of PTSD.
Scientists examining how COVID impacts the entire human body, not just the lungs, believe that there could be a link between the endothelium and Long COVID.
Senior Researcher in Social Science Michael Morrison explains why disruptive technologies need institutional and systemic readiness to truly realise the benefits of healthcare innovation.
Professor Olivier Braissant highlights here, how the challenges of treating genetic diseases can be exemplified by research on creatine transporter deficiency.
Gary Davies, from Sandvik Materials Technology, explains how medical wires are helping patients monitor blood glucose levels without the need for daily testing.
A patient with vaccine-inducted thrombotic thrombocytopenia was successfully treated with a heparin alternative, after receiving the Johnson & Johnson vaccine.
Robin Stern, Chair at Future Perfect (Healthcare), discusses how patient journeys currently reflect a national 'illness' service, not a national health service.
Researchers studied over 30,688 HIV patients across seven Latin American countries - finding that life expectancy has dramatically increased over a period of 14 years.
